Form 8-K - Current report:
SEC Accession No. 0001140361-25-046187
Filing Date
2025-12-19
Accepted
2025-12-19 16:05:47
Documents
12
Period of Report
2025-12-17
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K ef20061683_8k.htm   iXBRL 8-K 23877
  Complete submission text file 0001140361-25-046187.txt   149450

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ird-20251217.xsd EX-101.SCH 3860
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ird-20251217_lab.xml EX-101.LAB 21967
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ird-20251217_pre.xml EX-101.PRE 16042
15 EXTRACTED XBRL INSTANCE DOCUMENT ef20061683_8k_htm.xml XML 4051
Mailing Address 8 DAVIS DRIVE SUITE 220 DURHAM NC 27713
Business Address 8 DAVIS DRIVE SUITE 220 DURHAM NC 27713 248-681-9815
Opus Genetics, Inc. (Filer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34079 | Film No.: 251587528
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)